Pulmonary hypertension (PH) is a pathophysiological disorder that may involve multiple
clinical conditions and can complicate the majority of cardiovascular and respiratory …

The demands on a pulmonary arterial hypertension (PAH) treatment algorithm are multiple
and in some ways conflicting. The treatment algorithm usually includes different types of …

6.2. 2. Wydolność wysiłkowa......................... 1147 6.2. 3. Markery biochemiczne........................
1147 6.2. 4. Kompleksowa ocena rokownicza i oszacowanie ryzyka........................... 1148 6.2 …

Thus, the task of writing Guidelines or Expert Consensus documents covers not only the
integration of the most recent research, but also the creation of educational tools and …

Current guidelines for the treatment of patients with idiopathic pulmonary arterial
hypertension (IPAH) recommend basing therapeutic decision-making on haemodynamic …

Level of Evidence A Data derived from multiple randomised clinical trials or meta-analyses
Level of Evidence B Data derived from a single randomised clinical trial or large non …

With significant therapeutic advances in the field of pulmonary arterial hypertension, the
need to identify clinically relevant treatment goals that correlate with long-term outcome has …

肺高血压(pulmonary hypertension, PH) 是一大类以肺动脉压力增高, 伴或不伴有小肺动脉病变
为特征的恶性肺血管疾病, 往往引起右心功能衰竭甚至死亡[1]. PH 已成为一类严重威胁人类 …

Although idiopathic pulmonary arterial hypertension is perceived as a progressive disease
with a uniformly poor outcome, the natural history of disease is heterogeneous, with some …

Pulmonary hypertension is characterised by the chronic elevation of pulmonary artery
pressure (PAP) and pulmonary vascular resistance (PVR) leading to right ventricular …